NEW YORK, July 15, 2025 /PRNewswire/ -- SPRIM PRO and ObvioHealth, sister companies within the SPRIM Group, have expanded their…
Senolytic Immunotherapy Leader Expands Executive Team in Anticipation of Clinical Trial Launch MIAMI BEACH, Fla., July 15, 2025 /PRNewswire/ --…
New collaboration brings faster, digital-first counterfeit detection to the front lines of pharmaceutical brand protection. HELSINKI, July 15, 2025 /PRNewswire/…
CHICAGO, July 15, 2025 /PRNewswire/ -- EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today…
Recognized for strengthening digital capabilities across the Life Sciences value chainSOUTHBOROUGH, Mass., July 15, 2025 /PRNewswire/ -- Virtusa Corporation, a global…
Kester Capital-backed Evestia Clinical merges with US-based Atlantic Research Group (ARG) to create a leading independent global specialist CRO in…
$10 million securities purchase agreement provides efficient and flexible funding in support of strategic multi-million dollar growth initiatives Discussions underway…
First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting antibiotic-resistant lung infections…
Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage…
WATERTOWN, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,…